Aarthi Jayanthan - Translational Research Laboratories, The University of Calgary

基本信息

浏览量：27

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 74 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

RSK1 is an Exploitable Dependency in Myeloproliferative Neoplasms and Secondary Acute Myeloid Leukemia

Nature Communications（2025）

引用0浏览0WOSNATURE引用

RSK1 Dependency in FLT3-ITD Acute Myeloid Leukemia

Tim Kong,Angelo B. A. Laranjeira, Christopher T. Letson,Layow Yu,Fan He,Aarthi Jayanthan,Gerrit Los,Sandra E. Dunn,Grant A. Challen,Stephen T. Oh

BLOOD CANCER JOURNALno. 1 (2024)

引用1浏览0WOSNATURE引用

Abstract PO3-29-04: Patient Selection for High RSK2 Expression is Key for Achieving Improved PFS in Metastatic Breast Cancer in the PMD-026 Phase 1/1b Study

Sandra Dunn,Judy Wang,Hyo Han,Robert Wesolowski,Amita Patnaik,Shakeela Bahadur,Nicolaos Palaskas,My-my Huynh,Aarthi Jayanthan,Gerrit Los,Andrew Dorr

Cancer Researchno. 9_Supplement (2024): PO3-29

引用0浏览0引用

Patient Selection for High RSK2 Expression is Key for Achieving Improved PFS in Metastatic Breast Cancer in the PMD-026 Phase 1/ 1b Study

Sandra Dunn,Judy Wang,Hyo Han,Robert Wesolowski,Amita Patnaik,Shakeela Bahadur,Nicolaos Palaskas,My-My Huynh,Aarthi Jayanthan,Gerrit Los,Andrew Dorr

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

Abstract P4-01-16: High Levels of RSK2 in Breast Cancer Patients is Associated with Longer PFS in Patients Treated with PMD-026, a First in Class RSK Inhibitor

Judy S. Wang,Muralidhar Beeram,Pavani Chalasani,Lida Mina,Rebecca A. Shatsky,Sara Hurvitz,Meghna S. Trivedi,Robert Wesolowski,Hyo S. Han,Amita Patnaik,Shakeela Bahadur,My-my Huynh,Aarthi Jayanthan,Gerrit Los,Sandra E. Dunn,Andrew Dorr

Cancer Research（2023）

引用0浏览0引用

Inhibition of P90 Ribosomal S6 Kinases Disrupts Melanoma Cell Growth and Immune Evasion

Corinna Kosnopfel,Simone Wendlinger,Heike Niessner, Johannes Siewert,Tobias Sinnberg, Angelika Hofmann,Jonas Wohlfarth,David Schrama, Marion Berthold,Claudia Siedel,Birgit Sauer,Aarthi Jayanthan,Georg Lenz,Sandra E. Dunn,Bastian Schilling,Birgit Schittek

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH（2023）

引用7浏览0WOS引用

High Levels of RSK2 in Breast Cancer Patients is Associated with Longer PFS in Patients Treated with PMD-026, a First in Class RSK Inhibitor

Judy S. Wang,Muralidhar Beeram,Pavani Chalasani,Lida Mina,Rebecca A. Shatsky,Sara Hurvitz,Meghna S. Trivedi,Robert Wesolowski,Hyo S. Han,Amita Patnaik,Shakeela Bahadur,My-My Huynh,Aarthi Jayanthan,Gerrit Los,Sandra E. Dunn,Andrew Dorr

CANCER RESEARCH（2023）

引用0浏览0引用

Establishment of a T(11;19), KMT2A Rearranged B-ALL Cell Line for Preclinical Evaluation and Novel Therapeutics Development for Refractory Infant Leukemia

Ritul Sharma,Andrea Incoronato,Chunfen Zhang,Aarthi Jayanthan,Ravi Shah,Aru Narendran

Journal of Pediatric Hematology/Oncologyno. 6 (2023): e750-e756

引用0浏览0WOS引用

Abstract P5-17-12: First-in-human Expansion Study of Oral PMD-026 in Metastatic Triple Negative Breast Cancer Patients

Muralidhar Beeram,Judy S. Wang,Lida A. Mina,Pavani Chalasani,Rebecca A. Shatsky,Robert Wesolowski,Sara A. Hurvitz,Meghna S. Trivedi,Hyo S. Han,Amita Patnaik,My-my Huynh,Aarthi Jayanthan,Mary Rose Pambid,Lambert Yue,Gerrit Los,Sandra E. Dunn,Andrew Dorr

Cancer Researchno. 4_Supplement (2022): P5-12

引用0浏览0引用

PMD-026, a First in Class Oral RSK Inhibitor, Demonstrates Activity Against Hormone Receptor Positive Breast Cancer with Acquired CDK4/6 Inhibitor Resistance

Aarthi Jayanthan,Lambert Yue,My-my Huynh,Gerrit Los,Sandra E. Dunn

Cancer Researchno. 12_Supplement (2022): 5378-5378

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn